▶ 調査レポート

世界の組み換え試薬市場2023年:企業・地域・種類・用途別分析

• 英文タイトル:Global Recombination Reagent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の組み換え試薬市場2023年:企業・地域・種類・用途別分析 / Global Recombination Reagent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC309Z8029資料のイメージです。• レポートコード:MRC309Z8029
• 出版社/出版日:GlobalInfoResearch / 2023年9月
• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医薬品&ヘルスケア
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
GlobalInfoResearchの最新の調査によると、世界の組み換え試薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の組み換え試薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 組み換え試薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

組み換え試薬市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・相同組換え試薬、非相同組換え試薬、部位特異的組換え試薬、複製組換え試薬

用途別セグメント
・病院、製薬、研究所、その他

主要な市場プレーヤー
・Horizon Discovery Group、CRISPR Therapeutics、Sangamo Therapeutics、Intellia Therapeutics、Editas Medicine、Precision BioSciences、Pairwise Plants、Beam Therapeutics、Inscripta、Inari Agriculture

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、組み換え試薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な組み換え試薬メーカーの企業概要、2019年~2022年までの組み換え試薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な組み換え試薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別組み換え試薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの組み換え試薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での組み換え試薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および組み換え試薬の産業チェーンを掲載しています。
・第14、15章では、組み換え試薬の販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- 組み換え試薬の概要
- 種類別分析(2018年vs2022年vs2029年):相同組換え試薬、非相同組換え試薬、部位特異的組換え試薬、複製組換え試薬
- 用途別分析(2018年vs2022年vs2029年):病院、製薬、研究所、その他
- 世界の組み換え試薬市場規模・予測
- 世界の組み換え試薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Horizon Discovery Group、CRISPR Therapeutics、Sangamo Therapeutics、Intellia Therapeutics、Editas Medicine、Precision BioSciences、Pairwise Plants、Beam Therapeutics、Inscripta、Inari Agriculture
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:相同組換え試薬、非相同組換え試薬、部位特異的組換え試薬、複製組換え試薬
・用途別分析2018年-2029年:病院、製薬、研究所、その他
・組み換え試薬の北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・組み換え試薬のヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・組み換え試薬のアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・組み換え試薬の南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・組み換え試薬の中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Recombination Reagent market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Recombination Reagent refers to monoclonal reagents produced with recombinant DNA technology.
This report is a detailed and comprehensive analysis for global Recombination Reagent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Recombination Reagent market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Recombination Reagent market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Recombination Reagent market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Recombination Reagent market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombination Reagent
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombination Reagent market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Horizon Discovery Group, CRISPR Therapeutics, Sangamo Therapeutics, Intellia Therapeutics and Editas Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Recombination Reagent market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Homologous Recombination Reagent
Nonhomologous Recombination Reagent
Site-Specific Recombination Reagent
Replicative Recombination Reagent
Market segment by Application
Hospitals
Pharmaceuticals
Research Institutes
Others
Major players covered
Horizon Discovery Group
CRISPR Therapeutics
Sangamo Therapeutics
Intellia Therapeutics
Editas Medicine
Precision BioSciences
Pairwise Plants
Beam Therapeutics
Inscripta
Inari Agriculture
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombination Reagent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombination Reagent, with price, sales, revenue and global market share of Recombination Reagent from 2018 to 2023.
Chapter 3, the Recombination Reagent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombination Reagent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombination Reagent market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombination Reagent.
Chapter 14 and 15, to describe Recombination Reagent sales channel, distributors, customers, research findings and conclusion.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Recombination Reagent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombination Reagent Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Homologous Recombination Reagent
1.3.3 Nonhomologous Recombination Reagent
1.3.4 Site-Specific Recombination Reagent
1.3.5 Replicative Recombination Reagent
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombination Reagent Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Pharmaceuticals
1.4.4 Research Institutes
1.4.5 Others
1.5 Global Recombination Reagent Market Size & Forecast
1.5.1 Global Recombination Reagent Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Recombination Reagent Sales Quantity (2018-2029)
1.5.3 Global Recombination Reagent Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Horizon Discovery Group
2.1.1 Horizon Discovery Group Details
2.1.2 Horizon Discovery Group Major Business
2.1.3 Horizon Discovery Group Recombination Reagent Product and Services
2.1.4 Horizon Discovery Group Recombination Reagent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Horizon Discovery Group Recent Developments/Updates
2.2 CRISPR Therapeutics
2.2.1 CRISPR Therapeutics Details
2.2.2 CRISPR Therapeutics Major Business
2.2.3 CRISPR Therapeutics Recombination Reagent Product and Services
2.2.4 CRISPR Therapeutics Recombination Reagent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CRISPR Therapeutics Recent Developments/Updates
2.3 Sangamo Therapeutics
2.3.1 Sangamo Therapeutics Details
2.3.2 Sangamo Therapeutics Major Business
2.3.3 Sangamo Therapeutics Recombination Reagent Product and Services
2.3.4 Sangamo Therapeutics Recombination Reagent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sangamo Therapeutics Recent Developments/Updates
2.4 Intellia Therapeutics
2.4.1 Intellia Therapeutics Details
2.4.2 Intellia Therapeutics Major Business
2.4.3 Intellia Therapeutics Recombination Reagent Product and Services
2.4.4 Intellia Therapeutics Recombination Reagent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Intellia Therapeutics Recent Developments/Updates
2.5 Editas Medicine
2.5.1 Editas Medicine Details
2.5.2 Editas Medicine Major Business
2.5.3 Editas Medicine Recombination Reagent Product and Services
2.5.4 Editas Medicine Recombination Reagent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Editas Medicine Recent Developments/Updates
2.6 Precision BioSciences
2.6.1 Precision BioSciences Details
2.6.2 Precision BioSciences Major Business
2.6.3 Precision BioSciences Recombination Reagent Product and Services
2.6.4 Precision BioSciences Recombination Reagent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Precision BioSciences Recent Developments/Updates
2.7 Pairwise Plants
2.7.1 Pairwise Plants Details
2.7.2 Pairwise Plants Major Business
2.7.3 Pairwise Plants Recombination Reagent Product and Services
2.7.4 Pairwise Plants Recombination Reagent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pairwise Plants Recent Developments/Updates
2.8 Beam Therapeutics
2.8.1 Beam Therapeutics Details
2.8.2 Beam Therapeutics Major Business
2.8.3 Beam Therapeutics Recombination Reagent Product and Services
2.8.4 Beam Therapeutics Recombination Reagent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Beam Therapeutics Recent Developments/Updates
2.9 Inscripta
2.9.1 Inscripta Details
2.9.2 Inscripta Major Business
2.9.3 Inscripta Recombination Reagent Product and Services
2.9.4 Inscripta Recombination Reagent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Inscripta Recent Developments/Updates
2.10 Inari Agriculture
2.10.1 Inari Agriculture Details
2.10.2 Inari Agriculture Major Business
2.10.3 Inari Agriculture Recombination Reagent Product and Services
2.10.4 Inari Agriculture Recombination Reagent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Inari Agriculture Recent Developments/Updates
3 Competitive Environment: Recombination Reagent by Manufacturer
3.1 Global Recombination Reagent Sales Quantity by Manufacturer (2018-2023)
3.2 Global Recombination Reagent Revenue by Manufacturer (2018-2023)
3.3 Global Recombination Reagent Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Recombination Reagent by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Recombination Reagent Manufacturer Market Share in 2022
3.4.2 Top 6 Recombination Reagent Manufacturer Market Share in 2022
3.5 Recombination Reagent Market: Overall Company Footprint Analysis
3.5.1 Recombination Reagent Market: Region Footprint
3.5.2 Recombination Reagent Market: Company Product Type Footprint
3.5.3 Recombination Reagent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Recombination Reagent Market Size by Region
4.1.1 Global Recombination Reagent Sales Quantity by Region (2018-2029)
4.1.2 Global Recombination Reagent Consumption Value by Region (2018-2029)
4.1.3 Global Recombination Reagent Average Price by Region (2018-2029)
4.2 North America Recombination Reagent Consumption Value (2018-2029)
4.3 Europe Recombination Reagent Consumption Value (2018-2029)
4.4 Asia-Pacific Recombination Reagent Consumption Value (2018-2029)
4.5 South America Recombination Reagent Consumption Value (2018-2029)
4.6 Middle East and Africa Recombination Reagent Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Recombination Reagent Sales Quantity by Type (2018-2029)
5.2 Global Recombination Reagent Consumption Value by Type (2018-2029)
5.3 Global Recombination Reagent Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Recombination Reagent Sales Quantity by Application (2018-2029)
6.2 Global Recombination Reagent Consumption Value by Application (2018-2029)
6.3 Global Recombination Reagent Average Price by Application (2018-2029)
7 North America
7.1 North America Recombination Reagent Sales Quantity by Type (2018-2029)
7.2 North America Recombination Reagent Sales Quantity by Application (2018-2029)
7.3 North America Recombination Reagent Market Size by Country
7.3.1 North America Recombination Reagent Sales Quantity by Country (2018-2029)
7.3.2 North America Recombination Reagent Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Recombination Reagent Sales Quantity by Type (2018-2029)
8.2 Europe Recombination Reagent Sales Quantity by Application (2018-2029)
8.3 Europe Recombination Reagent Market Size by Country
8.3.1 Europe Recombination Reagent Sales Quantity by Country (2018-2029)
8.3.2 Europe Recombination Reagent Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Recombination Reagent Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Recombination Reagent Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Recombination Reagent Market Size by Region
9.3.1 Asia-Pacific Recombination Reagent Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Recombination Reagent Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Recombination Reagent Sales Quantity by Type (2018-2029)
10.2 South America Recombination Reagent Sales Quantity by Application (2018-2029)
10.3 South America Recombination Reagent Market Size by Country
10.3.1 South America Recombination Reagent Sales Quantity by Country (2018-2029)
10.3.2 South America Recombination Reagent Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Recombination Reagent Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Recombination Reagent Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Recombination Reagent Market Size by Country
11.3.1 Middle East & Africa Recombination Reagent Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Recombination Reagent Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Recombination Reagent Market Drivers
12.2 Recombination Reagent Market Restraints
12.3 Recombination Reagent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Recombination Reagent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombination Reagent
13.3 Recombination Reagent Production Process
13.4 Recombination Reagent Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombination Reagent Typical Distributors
14.3 Recombination Reagent Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer